Entering text into the input field will update the search result below

EyePoint Pharmaceuticals' (EYPT) CEO Nancy Lurker on Q4 2019 Results - Earnings Call Transcript

Mar. 05, 2020 3:18 PM ETEyePoint Pharmaceuticals, Inc. (EYPT)
SA Transcripts profile picture
SA Transcripts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2019 Earnings Conference Call March 5, 2020 8:30 AM ET

Company Participants

George Elston – Chief Financial Officer and Head-Corporate Development

Nancy Lurker – President and Chief Executive Officer

Scott Jones – Chief Commercial Officer

Dario Paggiarino – Senior Vice President and Chief Medical Officer

Conference Call Participants

Dana Flanders – Guggenheim Securities

Andrew D'Silva – B. Riley FBR

I-Eh Jen – Laidlaw & Company

Yi Chen – H.C. Wainwright


Good morning. My name is Sarah and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2019 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company’s request.

I would now like to turn the call over to George Elston, Chief Financial Officer and Head of Corporate Development of EyePoint Pharmaceuticals. Sir, you may begin.

George Elston

Thank you, Sarah, and thank you all for joining us on today’s conference call to discuss EyePoint Pharmaceuticals fourth quarter and full year 2019 financial results and recent corporate developments.

With me today is Nancy Lurker, EyePoint’s President and Chief Executive Officer; and Scott Jones, our Chief Commercial Officer. Nancy will provide a corporate overview as well as highlight recent pipeline developments and Scott will comment on recent progress made on our commercial launches. I will provide commentary on the fourth quarter and full year financial results after those updates and we will then open the call for your questions where we will be joined by Dr. Dario Paggiarino, Senior Vice President and Chief Medical Officer.

Earlier this morning, we issued a press release detailing our financial results as well as commercial

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About EYPT

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on EYPT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.